Eulerpool Terminal
The edge that pays for itself.
Current Oncopeptides forecasts and price targets in August 2026
Ø Analyst Price Targets
5.29 SEK
+213.28 %
Median
5.29 SEK
+213.28 %
Max
5.44 SEK
Min
5.24 SEK
Last Price
1.69 SEK
Buy
0
Hold
3
Sell
6
The average target price for Oncopeptides is 5.29 SEK. (+213.28 % above the current price)
The median price target of Oncopeptides is 5.29 SEK.
Stock analysts from many renowned investment banks are closely examining the Oncopeptides stock. They conclude their professional Oncopeptides stock analyses with a clear recommendation for the Oncopeptides stock. The forecasts and price targets of professional analysts can be a good indicator of how a stock will perform in the next quarter.
| Buy | Hold | Sell | Ø Analyst Price Targets | |
|---|---|---|---|---|
| 2026-02-01 | 0 | 3 | 6 | 5.29 SEK |
| 2026-01-01 | 0 | 3 | 6 | 5.29 SEK |
| 2025-12-01 | 0 | 3 | 6 | 5.29 SEK |
| 2025-12-01 | 0 | 3 | 6 | 5.29 SEK |
| 2025-11-01 | 0 | 3 | 6 | 5.29 SEK |
| 2025-11-01 | 0 | 3 | 6 | 7.05 SEK |
Oncopeptides Stock Forecast 2026: Revenue & Earnings Estimates
Analysts expect the following revenue and earnings for Oncopeptides in the coming fiscal years:
| Fiscal year | Revenue | Net Income | Earnings per share |
|---|---|---|---|
| 2026e | 141.00 M SEK | -119.00 M SEK | -0.46 SEK |
| 2027e | 239.00 M SEK | -62.00 M SEK | -0.24 SEK |
| 2028e | 328.00 M SEK | -14.00 M SEK | -0.05 SEK |